Publication | Closed Access

A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study

Neuro-oncologyGliomaMedicinePharmacologyAnti-cancer AgentHigh-grade GliomasCancer TreatmentOncologyRadiation Oncology